Brown–Forman (BF-B) valuation
Brown–Forman P/E ratio history
Brown–Forman trades at 18.5 times its earnings over the last twelve months and 16.9 times the earnings analysts expect over the next twelve. At its last 10 fiscal year ends its P/E ranged from 16.8 (year to Apr 2026) to 40.6 (year to Apr 2021), with a median of 33.5.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Apr 30, 2026 | $25.77 | $1.53 | 16.8 | 15.0 |
| Apr 30, 2025 | $34.84 | $1.84 | 18.9 | 18.9 |
| Apr 30, 2024 | $47.85 | $2.14 | 22.4 | 24.0 |
| Apr 30, 2023 | $65.09 | $1.63 | 39.9 | 33.2 |
| Apr 30, 2022 | $67.44 | $1.74 | 38.8 | 36.6 |
| Apr 30, 2021 | $76.28 | $1.88 | 40.6 | — |
| Apr 30, 2020 | $62.20 | $1.72 | 36.2 | — |
| Apr 30, 2019 | $53.29 | $1.73 | 30.8 | — |
| Apr 30, 2018 | $56.04 | $1.48 | 37.9 | — |
| Apr 30, 2017 | $37.86 | $1.37 | 27.6 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Brown–Forman valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Brown–FormanBF-B | $13.2B | 18.5 | 16.9 | 2.6 |
| McCormick &MKC | $12.7B | 8.6 | 14.8 | 1.7 |
| J.M. Smucker Company (The)SJM | $13.9B | 60.7 | 12.5 | 1.5 |
| Hormel FoodsHRL | $11.7B | 33.8 | 13.8 | 1.0 |
| CloroxCLX | $10.6B | 18.3 | 15.4 | 1.6 |
| General MillsGIS | $18.3B | — | 11.1 | 1.0 |
| Bunge GlobalBG | $18.6B | 16.2 | 9.0 | 0.2 |
| Tyson FoodsTSN | $20.1B | 35.2 | 15.0 | 0.4 |
| Constellation BrandsSTZ | $23.1B | 12.1 | 11.3 | 2.5 |
| Peer median | 18.3 | 13.1 | 1.3 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: BF-B financials · BF-B returns
No forecast, no recommendation. This page describes Brown–Forman from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.